Latest Updates

Monsanto will no longer be a company name

Both will jointly develop bioneedles for vaccines against measles and rubella

The company has not said what it will charge in Europe, where prices differ from country to country

Revenues for the fourth quarter rose to ₹ 1,722 crore Torrent Pharmaceuticals posted 11 per cent increase in consolidated net…

This is one of the ED's biggest attachment of assets under the stringent Prevention of Money Laundering Act this year The…

It is an innovative delivery system for vaccines

He will be responsible for Abbott’s continued growth and leadership in the country

To help people affected with multiple sclerosis continue to live fuller lives

He has over 25 years of experience in specialty business, strategic and commercial operations

The drug is indicated to be used for the prevention and control of postpartum haemorrhage

The drug was not approved by US FDA

Zumutor will use its proprietary antibody display platform to enhance Syngene’s discovery programmes

The 8th edition of the event will be held from August 22 - 24, 2018 at Gujarat University Convention Centre, Ahmedabad, Gujarat…

Novo expects to provide data from the remaining eight trials this year

Kicks off first part of $90 mn investment in India over 5 years

ACG is the only market-ready Track & Trace solutions provider in the world with L1 to L5 solutions capabilities that comply…

The product is to treat disorders associated with neurodegenerative diseases

The company is seeking shareholders' approval on its new name

The theme of IDMA-APA PAC 2018 was Best Practices for World Class Generics

Imfinzi is the first immunotherapy to be approved in this setting, giving AstraZeneca a chance to intervene relatively early in…